216 related articles for article (PubMed ID: 17390239)
1. Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer.
Herber DL
IDrugs; 2007 Apr; 10(4):227-9. PubMed ID: 17390239
[No Abstract] [Full Text] [Related]
2. Immunotherapy in anticancer responses.
Whelan M
Curr Opin Mol Ther; 2004 Feb; 6(1):8-9. PubMed ID: 15011775
[No Abstract] [Full Text] [Related]
3. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Moschella F; Proietti E; Capone I; Belardelli F
Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
5. Tumor immunology top 10 list.
Finn OJ
Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
[No Abstract] [Full Text] [Related]
6. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
7. Peptide-based vaccines for cancer therapy.
Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
[TBL] [Abstract][Full Text] [Related]
8. How much help does a vaccine-induced T-cell response need?
Weber JS; Mulé JJ
J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
[No Abstract] [Full Text] [Related]
9. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
10. Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004.
Pawelec G; Gouttefangeas C
Cancer Immunol Immunother; 2004 Aug; 53(8):755-8. PubMed ID: 15133632
[No Abstract] [Full Text] [Related]
11. [Peptide-based vaccine therapy for cancer patients].
Yamada A
Nihon Rinsho; 2005 Apr; 63 Suppl 4():602-7. PubMed ID: 15861717
[No Abstract] [Full Text] [Related]
12. Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.
Hanna MG; Howard J; Vermorken J
Hum Vaccin Immunother; 2014; 10(11):3286-96. PubMed ID: 25483649
[No Abstract] [Full Text] [Related]
13. Therapeutic Vaccines for Cancer Immunotherapy.
Wang J; Mamuti M; Wang H
ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
[TBL] [Abstract][Full Text] [Related]
14. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
Gjerstorff MF; Burns J; Ditzel HJ
Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
[TBL] [Abstract][Full Text] [Related]
15. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
[TBL] [Abstract][Full Text] [Related]
16. Immunochemotherapy of human cancer.
Gutterman JU; Mavligit GM; Reed RC; Hersh EM
Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443
[No Abstract] [Full Text] [Related]
17. CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany.
Diken M; Widenmeyer M; Gouttefangeas C; Welters MJ; Britten CM
Cancer Immunol Immunother; 2010 Sep; 59(9):1417-23. PubMed ID: 19771427
[No Abstract] [Full Text] [Related]
18. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
19. The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): meeting highlights. 11-13 November, 2009, Dublin, Ireland.
Umansky V
Immunotherapy; 2010 Mar; 2(2):151-4. PubMed ID: 20635923
[TBL] [Abstract][Full Text] [Related]
20. [Cancer immunotherapy].
Hurtado Ruano T
Rev Esp Oncol; 1984; 31(2):359-69. PubMed ID: 6545712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
